## Abstract A simple method is described for the preparation of 2‐[^125^I]iodohistamine‐labelled Δ^8^‐tetrahydrocannabinol‐11‐oic acid with high specific activity for use in radioimmunoassay. This compound is produced in high yield and shows excellent radiochemical stability when stored at 4°C. The
The preparation of 5′-iodo-125I-Δ8-THC; a radioligand for the radioimmunoassay of cannabinoids
✍ Scribed by Colin G. Pitt; Herbert H. Seltzman; Susan R. Setzer; David L. Williams
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- French
- Weight
- 306 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Nucleophilic exchange of 5′‐iodo‐Δ^8^‐THC and sodium iodide‐125 afforded 5′‐iodo‐^125^I‐Δ^8^THC with a maximum specific activity of 42 Ci/mmole. The specific activity could be increased to at least 100 Ci/mmole by iodide‐125 displacement of the corresponding 5′‐tosylate. A hapten 5′‐carboxy‐^14^C‐Δ^9^‐THC, for use in conjunction with this radioligand, was synthesized from 5′‐bromo‐Δ^8^‐THC.
📜 SIMILAR VOLUMES
## Abstract We describe the preparation of ^125^I labelling with a higher specific radioactivity of N(1‐ethyl ‐2‐pyrrolidyl‐methyl)2‐ methoxy ‐5‐ethyl sulfonyl benzamide, a potent biological analogue for sulpiride. The incorporation of iodine in the molecule was achieved by the substitution of arom
We have prepared (S)-5-chloro-3-[ 1251]iodo-2-methoxy-N-( l-azabicyclo[2.2.2]oct-3-yl)benzamide ([125I]DAIZAC, [ 1254-3) as a radioligand for characterization of the 5-HT-3 receptor. Preparation of the 3-tri-n-butylstannyl precursor was accomplished from the corresponding unlabeled DAIZAC by reactio